RT Conference Proceedings
T1 Real World Use of Afatinib in NSCLC EGFRm plus Patients Outside Clinical Trials: A FAETT Experience
A1 Ramos Garcia, I.
A1 Sanchez, A.
A1 Ortega, A. L.
A1 Pradera, J.
A1 Cobo, M.
A1 Moreno, M. A.
A1 Barneto, I.
A1 Ruiz, S.
A1 Fernandez, I.
A1 Garcia, T.
A1 Toscano, F.
A1 Trigo Perez, J. M.
K1 Older EGFRm plus NSCLC
PB Elsevier science inc
SN 1556-0864
YR 2019
FD 2019-10-01
LK https://hdl.handle.net/10668/25166
UL https://hdl.handle.net/10668/25166
LA en
DS RISalud
RD Apr 19, 2025